Invention Grant
- Patent Title: Polynucleotides encoding novel PCSK9 variants
-
Application No.: US13336371Application Date: 2011-12-23
-
Publication No.: US08354264B2Publication Date: 2013-01-15
- Inventor: Gabriel A. Mintier , Jian Chen , John N. Feder , Bowman Miao , Rex Arnold Parker
- Applicant: Gabriel A. Mintier , Jian Chen , John N. Feder , Bowman Miao , Rex Arnold Parker
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Melissa Miller
- Main IPC: C12N9/00
- IPC: C12N9/00 ; C12N9/50 ; C12N1/20 ; C12N15/00 ; C07H21/02 ; C07H21/04

Abstract:
The present invention provides novel polynucleotides encoding PCSK9b and PCSK9c polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel PCSK9b and PCSK9c polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
Public/Granted literature
- US20120129237A1 POLYNUCLEOTIDES ENCODING NOVEL PCSK9 VARIANTS Public/Granted day:2012-05-24
Information query